Header Logo

Connection

Anil Chandraker to Humans

Back to Details
This is a "connection" page, showing publications Anil Chandraker has written about Humans.
Anil Chandraker
Connection Strength
1.301
Humans
  1. Schreiber B, Tripathi S, Nikiforow S, Chandraker A. Adoptive Immune Effector Cell Therapies in Cancer and Solid Organ Transplantation: A Review. Semin Nephrol. 2024 Jan; 44(1):151498.
    View in: PubMed
    Score: 0.035
  2. Chandraker A, Regmi A, Gohh R, Sharma A, Woodle ES, Ansari MJ, Nair V, Chen LX, Alhamad T, Norman S, Cibrik D, Singh M, Alper A, Jain D, Zaky Z, Knechtle S, Sharfuddin A, Gupta G, Lonze BE, Young JH, Adey D, Faravardeh A, Dadhania DM, Rossi AP, Florescu D, Cardarelli F, Ma J, Gilmore S, Vasileiou S, Jindra PT, Wojciechowski D. Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. J Am Soc Nephrol. 2024 May 01; 35(5):618-629.
    View in: PubMed
    Score: 0.035
  3. Heo S, Park Y, Lee N, Kim Y, Kim YN, Shin HS, Jung Y, Rim H, Rennke HG, Chandraker A. Lack of Efficacy and Safety of Eculizumab for Treatment of Antibody-Mediated Rejection Following Renal Transplantation. Transplant Proc. 2022 Oct; 54(8):2117-2124.
    View in: PubMed
    Score: 0.031
  4. Tripathi S, Martin-Moreno PL, Kavalam G, Schreiber BL, Waaga-Gasser AM, Chandraker A. Adenosinergic Pathway and Linked Suppression: Two Critical Suppressive Mechanisms of Human Donor Antigen Specific Regulatory T Cell Lines Expanded Post Transplant. Front Immunol. 2022; 13:849939.
    View in: PubMed
    Score: 0.030
  5. Chandraker A. Introduction: Moving Toward a More Personalized Approach to Kidney Transplantation. Semin Nephrol. 2022 01; 42(1):1.
    View in: PubMed
    Score: 0.030
  6. Hod T, Isakov O, Patibandla BK, Christopher KB, Hershkoviz R, Schwartz IF, Chandraker A. Posttransplantation Hypomagnesemia as a Predictor of Better Graft Function after Transplantation. Kidney Blood Press Res. 2020; 45(6):982-995.
    View in: PubMed
    Score: 0.027
  7. Choi J, Chandraker A. Immunologic Risk Assessment and Approach to Immunosuppression Regimen in Kidney Transplantation. Clin Lab Med. 2019 12; 39(4):643-656.
    View in: PubMed
    Score: 0.025
  8. Chandraker A, Andreoni KA, Gaston RS, Gill J, Locke JE, Mathur AK, Norman DJ, Patzer RE, Rana A, Ratner LE, Schold JD, Pruett TL. Time for reform in transplant program-specific reporting: AST/ASTS transplant metrics taskforce. Am J Transplant. 2019 07; 19(7):1888-1895.
    View in: PubMed
    Score: 0.025
  9. Cai S, Zhao J, Ueno T, Chandraker A. Potential Roles of Siglecs in the Regulation of Allo-Immune Reaction. Curr Protein Pept Sci. 2019; 20(8):823-828.
    View in: PubMed
    Score: 0.024
  10. Cai S, Chandraker A. Cell Therapy in Solid Organ Transplantation. Curr Gene Ther. 2019; 19(2):71-80.
    View in: PubMed
    Score: 0.024
  11. Gabardi S, Pavlakis M, Tan C, Francis J, Cardarelli F, Asch W, Bodziak K, Chobanian M, Gilligan H, Gohh R, Kung SC, Inker L, Martin S, Rodig N, Rossi A, Chandraker A. New England BK consortium: Regional survey of BK screening and management protocols in comparison to published consensus guidelines. Transpl Infect Dis. 2018 Dec; 20(6):e12985.
    View in: PubMed
    Score: 0.024
  12. Martin-Moreno PL, Tripathi S, Chandraker A. Regulatory T Cells and Kidney Transplantation. Clin J Am Soc Nephrol. 2018 11 07; 13(11):1760-1764.
    View in: PubMed
    Score: 0.023
  13. Batal I, Mohan S, De Serres SA, Vasilescu ER, Tsapepas D, Crew RJ, Patel SS, Serban G, McCune K, Husain SA, Chang JH, Herter JM, Bhagat G, Markowitz GS, D'Agati VD, Hardy MA, Ratner L, Chandraker A. Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes. Kidney Int. 2018 05; 93(5):1227-1239.
    View in: PubMed
    Score: 0.023
  14. Grgic I, Chandraker A. Significance of biologics in renal transplantation: past, present, and future. Curr Opin Organ Transplant. 2018 02; 23(1):51-62.
    View in: PubMed
    Score: 0.023
  15. Shin HS, Chandraker A. Causes and management of postrenal transplant diarrhea: an underappreciated cause of transplant-associated morbidity. Curr Opin Nephrol Hypertens. 2017 11; 26(6):484-493.
    View in: PubMed
    Score: 0.022
  16. Newell KA, Formica RN, Gill JS, Schold JD, Allan JS, Covington SH, Wiseman AC, Chandraker A. Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference. Am J Transplant. 2017 04; 17(4):901-911.
    View in: PubMed
    Score: 0.021
  17. Pruett TL, Vathsala A, Berney T, Lerut J, Odorico JS, Johnson M, Egawa H, Gonzalez-Martinez F, Haberal M, Ascher NL, Chandraker AK. Criminal Organ Retrieval: Unconscionable. Am J Transplant. 2017 02; 17(2):577.
    View in: PubMed
    Score: 0.021
  18. Pruett TL, Chandraker A. The White House Organ Summit: What It Means for Our Field. Am J Transplant. 2016 08; 16(8):2245-6.
    View in: PubMed
    Score: 0.020
  19. Ueno T, Ikeda T, Yokoyama T, Kihara Y, Konno O, Nakamura Y, Iwamoto H, Shimizu T, McGrath MM, Chandraker A. Reduction in circulating level of HMGB-1 following continuous renal replacement therapy in sepsis. Cytokine. 2016 07; 83:206-209.
    View in: PubMed
    Score: 0.020
  20. Chandraker A, Arscott R, Murphy G, Lian C, Bueno E, Marty F, Rennke H, Milford E, Tullius S, Pomahac B. Face Transplantation in a Highly Sensitized Recipient. Mil Med. 2016 05; 181(5 Suppl):221-6.
    View in: PubMed
    Score: 0.020
  21. Chandraker A. The Real World Impact of APOL1 Variants on Kidney Transplantation. Transplantation. 2016 Jan; 100(1):16-7.
    View in: PubMed
    Score: 0.020
  22. Hod T, Riella LV, Chandraker A. Recombinant PTH therapy for severe hypoparathyroidism after kidney transplantation in pre-transplant parathyroidectomized patients: review of the literature and a case report. Clin Transplant. 2015 Nov; 29(11):951-7.
    View in: PubMed
    Score: 0.019
  23. Batal I, De Serres SA, Safa K, Bijol V, Ueno T, Onozato ML, Iafrate AJ, Herter JM, Lichtman AH, Mayadas TN, Guleria I, Rennke HG, Najafian N, Chandraker A. Dendritic Cells in Kidney Transplant Biopsy Samples Are Associated with T Cell Infiltration and Poor Allograft Survival. J Am Soc Nephrol. 2015 Dec; 26(12):3102-13.
    View in: PubMed
    Score: 0.019
  24. Riella LV, Safa K, Yagan J, Lee B, Azzi J, Najafian N, Abdi R, Milford E, Mah H, Gabardi S, Malek S, Tullius SG, Magee C, Chandraker A. Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch. Transplantation. 2014 Jun 27; 97(12):1247-52.
    View in: PubMed
    Score: 0.018
  25. Chandraker A, Arscott R, Murphy GF, Lian CG, Bueno EM, Marty FM, Rennke HG, Milford E, Tullius SG, Pomahac B. The management of antibody-mediated rejection in the first presensitized recipient of a full-face allotransplant. Am J Transplant. 2014 Jun; 14(6):1446-52.
    View in: PubMed
    Score: 0.017
  26. Lee BT, Gabardi S, Grafals M, Hofmann RM, Akalin E, Aljanabi A, Mandelbrot DA, Adey DB, Heher E, Fan PY, Conte S, Dyer-Ward C, Chandraker A. Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial. Clin J Am Soc Nephrol. 2014 Mar; 9(3):583-9.
    View in: PubMed
    Score: 0.017
  27. Safa K, Riella LV, Chandraker A. Beyond calcineurin inhibitors: emerging agents in kidney transplantation. Curr Opin Nephrol Hypertens. 2013 Nov; 22(6):689-97.
    View in: PubMed
    Score: 0.017
  28. Chandraker A, Strom TB. Transplantation: a new molecular approach to the diagnosis of acute rejection. Nat Rev Nephrol. 2013 Nov; 9(11):631-2.
    View in: PubMed
    Score: 0.017
  29. Gabardi S, Townsend K, Martin ST, Chandraker A. Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients. Transpl Infect Dis. 2013 Aug; 15(4):361-8.
    View in: PubMed
    Score: 0.016
  30. Riella LV, Paterson AM, Sharpe AH, Chandraker A. Role of the PD-1 pathway in the immune response. Am J Transplant. 2012 Oct; 12(10):2575-87.
    View in: PubMed
    Score: 0.016
  31. Riella LV, Chandraker A. Stem cell therapy in kidney transplantation. JAMA. 2012 Jul 11; 308(2):130; author reply 130-1.
    View in: PubMed
    Score: 0.015
  32. Riella LV, Gabardi S, Chandraker A. Dyslipidemia and its therapeutic challenges in renal transplantation. Am J Transplant. 2012 Aug; 12(8):1975-82.
    View in: PubMed
    Score: 0.015
  33. Gabardi S, Millen P, Hurwitz S, Martin S, Roberts K, Chandraker A. Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation. Clin Transplant. 2012 May-Jun; 26(3):E184-90.
    View in: PubMed
    Score: 0.015
  34. Lee BT, Kumar V, Williams TA, Abdi R, Bernhardy A, Dyer C, Conte S, Genovese G, Ross MD, Friedman DJ, Gaston R, Milford E, Pollak MR, Chandraker A. The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival. Am J Transplant. 2012 Jul; 12(7):1924-8.
    View in: PubMed
    Score: 0.015
  35. Sheashaa HA, Rennke HG, Bakr MA, Abbas TM, Atta AF, Sangak A, Mah H, Milford E, Chandraker A. Impact of accidental discovery of renal cell carcinoma at time of renal transplantation on patient or graft survival. Transplantation. 2011 Nov 27; 92(10):1123-8.
    View in: PubMed
    Score: 0.015
  36. Riella LV, Rennke HG, Grafals M, Chandraker A. Hypophosphatemia in kidney transplant recipients: report of acute phosphate nephropathy as a complication of therapy. Am J Kidney Dis. 2011 Apr; 57(4):641-5.
    View in: PubMed
    Score: 0.014
  37. Bedi DS, Riella LV, Tullius SG, Chandraker A. Animal models of chronic allograft injury: contributions and limitations to understanding the mechanism of long-term graft dysfunction. Transplantation. 2010 Nov 15; 90(9):935-44.
    View in: PubMed
    Score: 0.014
  38. Lin J, Kramer H, Chandraker AK. Mortality among living kidney donors and comparison populations. N Engl J Med. 2010 Aug 19; 363(8):797-8.
    View in: PubMed
    Score: 0.014
  39. Gabardi S, Waikar SS, Martin S, Roberts K, Chen J, Borgi L, Sheashaa H, Dyer C, Malek SK, Tullius SG, Vadivel N, Grafals M, Abdi R, Najafian N, Milford E, Chandraker A. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol. 2010 Jul; 5(7):1298-304.
    View in: PubMed
    Score: 0.013
  40. Vadivel N, Surana SP, Galvez-Trevino R, Chandraker AK. Quiz page May 2010: debilitating pain of the hands and feet following kidney transplant. Am J Kidney Dis. 2010 May; 55(5):A33-5.
    View in: PubMed
    Score: 0.013
  41. Chandraker A, Mannon RB. Care of the kidney transplant recipient. Clin J Am Soc Nephrol. 2008 Mar; 3 Suppl 2:S27-8.
    View in: PubMed
    Score: 0.011
  42. Winkelmayer WC, Chandraker A. Pottransplantation anemia: management and rationale. Clin J Am Soc Nephrol. 2008 Mar; 3 Suppl 2:S49-55.
    View in: PubMed
    Score: 0.011
  43. Vadivel N, Tullius SG, Chandraker A. Chronic allograft nephropathy. Semin Nephrol. 2007 Jul; 27(4):414-29.
    View in: PubMed
    Score: 0.011
  44. Vadivel N, Trikudanathan S, Chandraker A. Transplant tolerance through costimulation blockade--are we there yet? Front Biosci. 2007 May 01; 12:2935-46.
    View in: PubMed
    Score: 0.011
  45. Pendse SS, Vadivel N, Ramos E, Mudge GH, Von Visger T, Fang JC, Chandraker A. BK viral reactivation in cardiac transplant patients: evidence for a double-hit hypothesis. J Heart Lung Transplant. 2006 Jul; 25(7):814-9.
    View in: PubMed
    Score: 0.010
  46. Tinckam KJ, Chandraker A. Mechanisms and role of HLA and non-HLA alloantibodies. Clin J Am Soc Nephrol. 2006 May; 1(3):404-14.
    View in: PubMed
    Score: 0.010
  47. Chandraker A, Tullius SG. Induction therapy: are we picking our battles? Clin J Am Soc Nephrol. 2006 May; 1(3):356-7.
    View in: PubMed
    Score: 0.010
  48. Ansari MJ, Tinckam K, Chandraker A. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med. 2005 May 12; 352(19):2027-8; author reply 2027-8.
    View in: PubMed
    Score: 0.009
  49. Gabardi S, Magee CC, Baroletti SA, Powelson JA, Cina JL, Chandraker AK. Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: a single-center, retrospective analysis. Pharmacotherapy. 2004 Oct; 24(10):1323-30.
    View in: PubMed
    Score: 0.009
  50. Halleck F, B?hmig GA, Couzi L, Rostaing L, Einecke G, Lefaucheur C, Legendre C, Montgomery R, Hughes P, Chandraker A, Wyburn K, Halloran P, Maldonado AQ, Sj?holm K, Runstr?m A, Lef?vre P, Tollemar J, Jordan S. A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody-Mediated Rejection. Clin Transplant. 2024 Jul; 38(7):e15383.
    View in: PubMed
    Score: 0.009
  51. Huck DM, Buckley LF, Chandraker A, Blankstein R, Weber B. Targeting Pharmacotherapies for Inflammatory and Cardiorenal Endpoints in Kidney Disease. J Cardiovasc Pharmacol. 2024 06 01; 83(6):511-521.
    View in: PubMed
    Score: 0.009
  52. Winkelmayer WC, Kewalramani R, Rutstein M, Gabardi S, Vonvisger T, Chandraker A. Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol. 2004 May; 15(5):1347-52.
    View in: PubMed
    Score: 0.009
  53. Izawa A, Sayegh MH, Chandraker A. The antagonism of calcineurin inhibitors and costimulatory blockers: fact or fiction? Transplant Proc. 2004 Mar; 36(2 Suppl):570S-573S.
    View in: PubMed
    Score: 0.009
  54. Hanna GJ, Dharanesswaran H, Giobbie-Hurder A, Harran JJ, Liao Z, Pai L, Tchekmedyian V, Ruiz ES, Waldman AH, Schmults CD, Riella LV, Lizotte P, Paweletz CP, Chandraker AK, Murakami N, Silk AW. Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma. J Clin Oncol. 2024 Mar 20; 42(9):1021-1030.
    View in: PubMed
    Score: 0.009
  55. Huck DM, Weber B, Schreiber B, Pandav J, Parks S, Hainer J, Brown JM, Divakaran S, Blankstein R, Dorbala S, Trinquart L, Chandraker A, Di Carli MF. Comparative Effectiveness of PET and SPECT MPI for Predicting Cardiovascular Events After Kidney Transplant. Circ Cardiovasc Imaging. 2024 01; 17(1):e015858.
    View in: PubMed
    Score: 0.009
  56. Raina R, Jothi S, Haffner D, Somers M, Filler G, Vasistha P, Chakraborty R, Shapiro R, Randhawa PS, Parekh R, Licht C, Bunchman T, Sethi S, Mangat G, Zaritsky J, Schaefer F, Warady B, Bartosh S, McCulloch M, Alhasan K, Swiatecka-Urban A, Smoyer WE, Chandraker A, Yap HK, Jha V, Bagga A, Radhakrishnan J. Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements. Kidney Int. 2024 Mar; 105(3):450-463.
    View in: PubMed
    Score: 0.009
  57. Isakov O, Patibandla BK, Christopher KB, Chandraker A, Hod T. Impact of Post-Transplantation Hypomagnesemia on Long-Term Graft and Patient Survival after Transplantation. Kidney Blood Press Res. 2022; 47(5):341-353.
    View in: PubMed
    Score: 0.008
  58. Watts AJB, Keller KH, Lerner G, Rosales I, Collins AB, Sekulic M, Waikar SS, Chandraker A, Riella LV, Alexander MP, Troost JP, Chen J, Fermin D, Yee JL, Sampson MG, Beck LH, Henderson JM, Greka A, Rennke HG, Weins A. Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology. J Am Soc Nephrol. 2022 01; 33(1):238-252.
    View in: PubMed
    Score: 0.007
  59. M Courtwright A, Patel N, Chandraker A, J Goldberg H. Human leukocyte antigen antibody sensitization, lung transplantation, and health equity. Am J Transplant. 2022 03; 22(3):698-704.
    View in: PubMed
    Score: 0.007
  60. Garg N, Mandelbrot DA, Parajuli S, Aziz F, Astor BC, Chandraker A, Djamali A. The clinical value of donor-derived cell-free DNA measurements in kidney transplantation. Transplant Rev (Orlando). 2021 12; 35(4):100649.
    View in: PubMed
    Score: 0.007
  61. Kauke M, Panayi AC, Safi AF, Haug V, Perry B, Kollar B, Nizzi MC, Broyles J, Annino DJ, Marty FM, Sinha I, Lian CG, Murphy GF, Chandraker A, Pomahac B. Full facial retransplantation in a female patient-Technical, immunologic, and clinical considerations. Am J Transplant. 2021 10; 21(10):3472-3480.
    View in: PubMed
    Score: 0.007
  62. Win TS, Crisler WJ, Dyring-Andersen B, Lopdrup R, Teague JE, Zhan Q, Barrera V, Ho Sui S, Tasigiorgos S, Murakami N, Chandraker A, Tullius SG, Pomahac B, Riella LV, Clark RA. Immunoregulatory and lipid presentation pathways are upregulated in human face transplant rejection. J Clin Invest. 2021 04 15; 131(8).
    View in: PubMed
    Score: 0.007
  63. Mohammed MT, Cai S, Hanson BL, Zhang H, Clement RL, Daccache J, Cavazzoni CB, Blazar BR, Alessandrini A, Rennke HG, Chandraker A, Sage PT. Follicular T cells mediate donor-specific antibody and rejection after solid organ transplantation. Am J Transplant. 2021 05; 21(5):1893-1901.
    View in: PubMed
    Score: 0.007
  64. Goes N, Chandraker A. Human leukocyte antigen matching in renal transplantation: an update. Curr Opin Nephrol Hypertens. 2000 Nov; 9(6):683-7.
    View in: PubMed
    Score: 0.007
  65. Palsson R, Chandraker AK, Curhan GC, Rennke HG, McMahon GM, Waikar SS. The association of calcium oxalate deposition in kidney allografts with graft and patient survival. Nephrol Dial Transplant. 2020 05 01; 35(5):888-894.
    View in: PubMed
    Score: 0.007
  66. Chandraker A. Diagnostic techniques in the work-up of renal allograft dysfunction--an update. Curr Opin Nephrol Hypertens. 1999 Nov; 8(6):723-8.
    View in: PubMed
    Score: 0.006
  67. Siedlecki AM, Benson C, Frates M, Azzi J, Hoffman RJ, Milford E, Weins A, Chandraker A, Mc Donald N, Philip White J, Abdi R. First Report of Perfluorobutane Microsphere-Enhanced Ultrasound in the Transplant Kidney. Transplantation. 2019 10; 103(10):e283-e284.
    View in: PubMed
    Score: 0.006
  68. Starling RC, Armstrong B, Bridges ND, Eisen H, Givertz MM, Kfoury AG, Kobashigawa J, Ikle D, Morrison Y, Pinney S, Stehlik J, Tripathi S, Sayegh MH, Chandraker A. Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation. J Am Coll Cardiol. 2019 07 09; 74(1):36-51.
    View in: PubMed
    Score: 0.006
  69. Tasigiorgos S, Kollar B, Turk M, Perry B, Alhefzi M, Kiwanuka H, Nizzi MC, Marty FM, Chandraker A, Tullius SG, Riella LV, Pomahac B. Five-Year Follow-up after Face Transplantation. N Engl J Med. 2019 06 27; 380(26):2579-2581.
    View in: PubMed
    Score: 0.006
  70. Stehlik J, Armstrong B, Baran DA, Bridges ND, Chandraker A, Gordon R, De Marco T, Givertz MM, Heroux A, Ikl? D, Hunt J, Kfoury AG, Madsen JC, Morrison Y, Feller E, Pinney S, Tripathi S, Heeger PS, Starling RC. Early immune biomarkers and intermediate-term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation-18. Am J Transplant. 2019 05; 19(5):1518-1528.
    View in: PubMed
    Score: 0.006
  71. Murakami N, Ding Y, Cohen DJ, Chandraker AK, Rennke HG. Recurrent membranous nephropathy and acute cellular rejection in a patient treated with direct anti-HCV therapy (ledipasvir/sofosbuvir). Transpl Infect Dis. 2018 Oct; 20(5):e12959.
    View in: PubMed
    Score: 0.006
  72. D'Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, Bassi R, Tezza S, Dellepiane S, El Essawy B, Iascone M, Iacovoni A, Borgese L, Liu K, Visner G, Dhe-Paganon S, Corradi D, Abdi R, Starling RC, Folli F, Zuccotti GV, Sayegh MH, Heeger PS, Chandraker A, Grigioni F, Fiorina P. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018 08 01; 128(8):3490-3503.
    View in: PubMed
    Score: 0.006
  73. Tambur AR, Campbell P, Claas FH, Feng S, Gebel HM, Jackson AM, Mannon RB, Reed EF, Tinckam K, Askar M, Chandraker A, Chang PP, Colvin M, Demetris AJ, Diamond JM, Dipchand AI, Fairchild RL, Ford ML, Friedewald J, Gill RG, Glotz D, Goldberg H, Hachem R, Knechtle S, Kobashigawa J, Levine DJ, Levitsky J, Mengel M, Milford E, Newell KA, O'Leary JG, Palmer S, Randhawa P, Smith J, Snyder L, Starling RC, Sweet S, Taner T, Taylor CJ, Woodle S, Zeevi A, Nickerson P. Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report. Am J Transplant. 2018 07; 18(7):1604-1614.
    View in: PubMed
    Score: 0.006
  74. Schold JD, Andreoni KA, Chandraker AK, Gaston RS, Locke JE, Mathur AK, Pruett TL, Rana A, Ratner LE, Buccini LD. Expanding clarity or confusion? Volatility of the 5-tier ratings assessing quality of transplant centers in the United States. Am J Transplant. 2018 06; 18(6):1494-1501.
    View in: PubMed
    Score: 0.006
  75. Sula Karreci E, Eskandari SK, Dotiwala F, Routray SK, Kurdi AT, Assaker JP, Luckyanchykov P, Mihali AB, Maarouf O, Borges TJ, Alkhudhayri A, Patel KR, Radwan A, Ghobrial I, McGrath M, Chandraker A, Riella LV, Elyaman W, Abdi R, Lieberman J, Azzi J. Human regulatory T cells undergo self-inflicted damage via granzyme pathways upon activation. JCI Insight. 2017 11 02; 2(21).
    View in: PubMed
    Score: 0.006
  76. Park J, Lin HY, Assaker JP, Jeong S, Huang CH, Kurdi T, Lee K, Fraser K, Min C, Eskandari S, Routray S, Tannous B, Abdi R, Riella L, Chandraker A, Castro CM, Weissleder R, Lee H, Azzi JR. Integrated Kidney Exosome Analysis for the Detection of Kidney Transplant Rejection. ACS Nano. 2017 11 28; 11(11):11041-11046.
    View in: PubMed
    Score: 0.006
  77. Ryou M, McQuaid KR, Thompson CC, Edmundowicz S, Mergener K, Abu Dayyeh B, Apovian C, Burke C, Chand B, Chandraker A, Deas T, Dietz W, Dunkin B, Ernest O, Faigel D, Garber S, Hamdy O, Kaplan L, Kumar N, Kushner R, Larsen MC, Lerner H, Littenberg G, Mantzoros C, Mattar S, Moore R, Rinella M, Rothstein R, Schillinger D, Spring B, Sullivan S, Tice J, Vargo J, Wilson E, Woods K, Zundel N. ASGE EndoVators Summit: Defining the role and value of endoscopic therapies in obesity management. Gastrointest Endosc. 2017 11; 86(5):757-767.
    View in: PubMed
    Score: 0.006
  78. D?sy O, B?land S, Vallin P, Riopel J, Latulippe E, Najafian N, Chandraker A, Agharazii M, Batal I, De Serres SA. IL-6 production by monocytes is associated with graft function decline in patients with borderline changes suspicious for acute T-cell-mediated rejection: a pilot study. Transpl Int. 2018 01; 31(1):92-101.
    View in: PubMed
    Score: 0.006
  79. Ryou M, McQuaid KR, Thompson CC, Edmundowicz S, Mergener K, Dayyeh BA, Apovian C, Burke C, Chand B, Chandraker A, Deas T, Dietz W, Dunkin B, Ernest O, Faigel D, Garber S, Hamdy O, Kaplan L, Kumar N, Kushner R, Larsen MC, Lerner H, Littenberg G, Mantzoros C, Mattar S, Moore R, Rinella M, Rothstein R, Schillinger D, Spring B, Sullivan S, Tice J, Vargo J, Wilson E, Woods K, Zundel N. ASGE EndoVators Summit: Defining the role and value of endoscopic therapies in obesity management. Surg Obes Relat Dis. 2017 11; 13(11):1805-1816.
    View in: PubMed
    Score: 0.006
  80. Zazueta OE, Preston SE, Moniodis A, Fried S, Kim M, Townsend K, Wood I, Boukedes S, Guleria I, Camp P, El-Chemaly S, Rosas IO, Chandraker A, Milford E, Goldberg HJ. The Presence of Pretransplant HLA Antibodies Does Not Impact the Development of Chronic Lung Allograft Dysfunction or CLAD-Related Death. Transplantation. 2017 09; 101(9):2207-2212.
    View in: PubMed
    Score: 0.005
  81. Giwa S, Lewis JK, Alvarez L, Langer R, Roth AE, Church GM, Markmann JF, Sachs DH, Chandraker A, Wertheim JA, Rothblatt M, Boyden ES, Eidbo E, Lee WPA, Pomahac B, Brandacher G, Weinstock DM, Elliott G, Nelson D, Acker JP, Uygun K, Schmalz B, Weegman BP, Tocchio A, Fahy GM, Storey KB, Rubinsky B, Bischof J, Elliott JAW, Woodruff TK, Morris GJ, Demirci U, Brockbank KGM, Woods EJ, Ben RN, Baust JG, Gao D, Fuller B, Rabin Y, Kravitz DC, Taylor MJ, Toner M. The promise of organ and tissue preservation to transform medicine. Nat Biotechnol. 2017 06 07; 35(6):530-542.
    View in: PubMed
    Score: 0.005
  82. DeWolfe D, Gandhi J, Mackenzie MR, Broge TA, Bord E, Babwah A, Mandelbrot DA, Pavlakis M, Cardarelli F, Viscidi R, Chandraker A, Tan CS. Pre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients. PLoS One. 2017; 12(5):e0177339.
    View in: PubMed
    Score: 0.005
  83. Asare A, Kanaparthi S, Lim N, Phippard D, Vincenti F, Friedewald J, Pavlakis M, Poggio E, Heeger P, Mannon R, Burrell BE, Morrison Y, Bridges N, Sanz I, Chandraker A, Newell KA, Turka LA. B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function. Am J Transplant. 2017 Oct; 17(10):2627-2639.
    View in: PubMed
    Score: 0.005
  84. Jiamjariyapon T, Ingsathit A, Pongpirul K, Vipattawat K, Kanchanakorn S, Saetie A, Kanistanon D, Wongprompitak P, Leesmidt V, Watcharasaksilp W, Wang W, Chandraker AK, Tungsanga K. Effectiveness of Integrated Care on Delaying Progression of stage 3-4 Chronic Kidney Disease in Rural Communities of Thailand (ESCORT study): a cluster randomized controlled trial. BMC Nephrol. 2017 03 02; 18(1):83.
    View in: PubMed
    Score: 0.005
  85. Bassi R, Niewczas MA, Biancone L, Bussolino S, Merugumala S, Tezza S, D'Addio F, Ben Nasr M, Valderrama-Vasquez A, Usuelli V, De Zan V, El Essawy B, Venturini M, Secchi A, De Cobelli F, Lin A, Chandraker A, Fiorina P. Metabolomic Profiling in Individuals with a Failing Kidney Allograft. PLoS One. 2017; 12(1):e0169077.
    View in: PubMed
    Score: 0.005
  86. Grimmig T, Moench R, Kreckel J, Haack S, Rueckert F, Rehder R, Tripathi S, Ribas C, Chandraker A, Germer CT, Gasser M, Waaga-Gasser AM. Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer. Int J Mol Sci. 2016 Dec 08; 17(12).
    View in: PubMed
    Score: 0.005
  87. Cardarelli F, Bijol V, Chandraker A, Varga C, Riella LV. Acute myeloid leukemia after kidney transplantation: a case report and literature review. J Bras Nefrol. 2016 Dec; 38(4):455-461.
    View in: PubMed
    Score: 0.005
  88. Moench R, Grimmig T, Kannen V, Tripathi S, Faber M, Moll EM, Chandraker A, Lissner R, Germer CT, Waaga-Gasser AM, Gasser M. Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer. Oncotarget. 2016 Oct 18; 7(42):68749-68767.
    View in: PubMed
    Score: 0.005
  89. Weissenbacher A, Loupy A, Chandraker A, Schneeberger S. Donor-specific antibodies and antibody-mediated rejection in vascularized composite allotransplantation. Curr Opin Organ Transplant. 2016 10; 21(5):510-5.
    View in: PubMed
    Score: 0.005
  90. Javaheri A, Molina M, Zamani P, Rodrigues A, Novak E, Chambers S, Stutman P, Maslanek W, Williams M, Lilly SM, Heeger P, Sayegh MH, Chandraker A, Briscoe DM, Daly KP, Starling R, Ikle D, Christie J, Rame JE, Goldberg LR, Billheimer J, Rader DJ. Cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipients. J Heart Lung Transplant. 2016 11; 35(11):1295-1302.
    View in: PubMed
    Score: 0.005
  91. Lin MV, Sise ME, Pavlakis M, Amundsen BM, Chute D, Rutherford AE, Chung RT, Curry MP, Hanifi JM, Gabardi S, Chandraker A, Heher EC, Elias N, Riella LV. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection. PLoS One. 2016; 11(7):e0158431.
    View in: PubMed
    Score: 0.005
  92. Borges TJ, O'Malley JT, Wo L, Murakami N, Smith B, Azzi J, Tripathi S, Lane JD, Bueno EM, Clark RA, Tullius SG, Chandraker A, Lian CG, Murphy GF, Strom TB, Pomahac B, Najafian N, Riella LV. Codominant Role of Interferon-?- and Interleukin-17-Producing T Cells During Rejection in Full Facial Transplant Recipients. Am J Transplant. 2016 07; 16(7):2158-71.
    View in: PubMed
    Score: 0.005
  93. Starling RC, Stehlik J, Baran DA, Armstrong B, Stone JR, Ikle D, Morrison Y, Bridges ND, Putheti P, Strom TB, Bhasin M, Guleria I, Chandraker A, Sayegh M, Daly KP, Briscoe DM, Heeger PS. Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study. Am J Transplant. 2016 Jan; 16(1):121-36.
    View in: PubMed
    Score: 0.005
  94. Grimmig T, Matthes N, Hoeland K, Tripathi S, Chandraker A, Grimm M, Moench R, Moll EM, Friess H, Tsaur I, Blaheta RA, Germer CT, Waaga-Gasser AM, Gasser M. TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer. Int J Oncol. 2015 Sep; 47(3):857-66.
    View in: PubMed
    Score: 0.005
  95. Gabardi S, Ramasamy S, Kim M, Klasek R, Carter D, Mackenzie MR, Chandraker A, Tan CS. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia. Transpl Infect Dis. 2015 Aug; 17(4):536-43.
    View in: PubMed
    Score: 0.005
  96. Fischer S, Lian CG, Kueckelhaus M, Strom TB, Edelman ER, Clark RA, Murphy GF, Chandraker AK, Riella LV, Tullius SG, Pomahac B. Acute rejection in vascularized composite allotransplantation. Curr Opin Organ Transplant. 2014 Dec; 19(6):531-44.
    View in: PubMed
    Score: 0.005
  97. Batal I, De Serres SA, Mfarrej BG, Grafals M, Pinkus GS, Kalra A, Weins A, Bijol V, Rennke HG, Guleria I, Abdi R, Chandraker A, Najafian N. Glomerular inflammation correlates with endothelial injury and with IL-6 and IL-1? secretion in the peripheral blood. Transplantation. 2014 May 27; 97(10):1034-42.
    View in: PubMed
    Score: 0.004
  98. Kim M, Townsend KR, Wood IG, Boukedes S, Guleria I, Gabardi S, El-Chemaly S, Camp PC, Chandraker AK, Milford EL, Goldberg HJ. Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates. Am J Respir Crit Care Med. 2014 May 15; 189(10):1234-9.
    View in: PubMed
    Score: 0.004
  99. Lian CG, Bueno EM, Granter SR, Laga AC, Saavedra AP, Lin WM, Susa JS, Zhan Q, Chandraker AK, Tullius SG, Pomahac B, Murphy GF. Biomarker evaluation of face transplant rejection: association of donor T cells with target cell injury. Mod Pathol. 2014 Jun; 27(6):788-99.
    View in: PubMed
    Score: 0.004
  100. Vergani A, Tezza S, Fotino C, Visner G, Pileggi A, Chandraker A, Fiorina P. The purinergic system in allotransplantation. Am J Transplant. 2014 Mar; 14(3):507-14.
    View in: PubMed
    Score: 0.004
  101. Daly KP, Seifert ME, Chandraker A, Zurakowski D, Nohria A, Givertz MM, Karumanchi SA, Briscoe DM. VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients. J Heart Lung Transplant. 2013 Jan; 32(1):120-8.
    View in: PubMed
    Score: 0.004
  102. De Serres SA, Mfarrej BG, Grafals M, Riella LV, Magee CN, Yeung MY, Dyer C, Ahmad U, Chandraker A, Najafian N. Derivation and validation of a cytokine-based assay to screen for acute rejection in renal transplant recipients. Clin J Am Soc Nephrol. 2012 Jun; 7(6):1018-25.
    View in: PubMed
    Score: 0.004
  103. Gabardi S, Catella J, Martin ST, Perrone R, Chandraker A, Magee CC, McDevitt-Potter LM. Maintenance immunosuppression with intermittent intravenous IL-2 receptor antibody therapy in renal transplant recipients. Ann Pharmacother. 2011 Sep; 45(9):e48.
    View in: PubMed
    Score: 0.004
  104. Tsaur I, Karalis A, Blaheta R, Juengel E, Vallo S, Scheuermann EH, Kachel HG, Waaga-Gasser AM, Chandraker A, Oberm?ller N, Probst M. Transitional cell carcinoma of the native urinary tract after kidney transplantation: recommendations following a long-term retrospective analysis. Am J Med Sci. 2011 Jun; 341(6):478-83.
    View in: PubMed
    Score: 0.004
  105. Martin ST, Roberts KL, Malek SK, Tullius SG, Vadivel N, De Serres S, Grafals M, Elsanjak A, Filkins BA, Chandraker A, Gabardi S. Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal. Pharmacotherapy. 2011 Jun; 31(6):566-73.
    View in: PubMed
    Score: 0.004
  106. De Serres SA, Vadivel N, Mfarrej BG, Grafals M, DeJoseph M, Dyer C, Magee CN, Chandraker A, Gallon LG, Najafian N. Monocyte-secreted inflammatory cytokines are associated with transplant glomerulopathy in renal allograft recipients. Transplantation. 2011 Mar 15; 91(5):552-9.
    View in: PubMed
    Score: 0.004
  107. Lin J, McGovern ME, Brunelli SM, Gaccione P, Malek S, Tullius SG, Chandraker AK, Milford EL. Longitudinal trends and influence of BMI mismatch in living kidney donors and their recipients. Int Urol Nephrol. 2011 Sep; 43(3):891-7.
    View in: PubMed
    Score: 0.004
  108. Tsaur I, Gasser M, Aviles B, Lutz J, Lutz L, Grimm M, Lange V, Lopau K, Heemann U, Germer CT, Chandraker A, Waaga-Gasser AM. Donor antigen-specific regulatory T-cell function affects outcome in kidney transplant recipients. Kidney Int. 2011 May; 79(9):1005-12.
    View in: PubMed
    Score: 0.003
  109. Erickson AL, Roberts K, Malek SK, Chandraker AK, Tullius SG, Gabardi S. Analysis of infusion-site reactions in renal transplant recipients receiving peripherally administered rabbit antithymocyte globulin as compared with basiliximab. Transpl Int. 2010 Jun; 23(6):636-40.
    View in: PubMed
    Score: 0.003
  110. Pomahac B, Aflaki P, Chandraker A, Pribaz JJ. Facial transplantation and immunosuppressed patients: a new frontier in reconstructive surgery. Transplantation. 2008 Jun 27; 85(12):1693-7.
    View in: PubMed
    Score: 0.003
  111. Huurman VA, Unger WW, Koeleman BP, Oaks MK, Chandraker AK, Terpstra OT, Roep BO. Differential inhibition of autoreactive memory- and alloreactive naive T cell responses by soluble cytotoxic T lymphocyte antigen 4 (sCTLA4), CTLA4Ig and LEA29Y. Clin Exp Immunol. 2007 Dec; 150(3):487-93.
    View in: PubMed
    Score: 0.003
  112. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med. 2007 Aug; 13(8):952-61.
    View in: PubMed
    Score: 0.003
  113. Gabardi S, Kubiak DW, Chandraker AK, Tullius SG. Invasive fungal infections and antifungal therapies in solid organ transplant recipients. Transpl Int. 2007 Dec; 20(12):993-1015.
    View in: PubMed
    Score: 0.003
  114. Winkelmayer WC, Mehta J, Chandraker A, Owen WF, Avorn J. Predialysis nephrologist care and access to kidney transplantation in the United States. Am J Transplant. 2007 Apr; 7(4):872-9.
    View in: PubMed
    Score: 0.003
  115. Winkelmayer WC, Schaeffner ES, Chandraker A, Kramar R, Rumpold H, Sunder-Plassmann G, F?dinger M. A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients. Transpl Int. 2007 Jun; 20(6):505-11.
    View in: PubMed
    Score: 0.003
  116. Ali SH, Chandraker A, DeCaprio JA. Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones. Antivir Ther. 2007; 12(1):1-6.
    View in: PubMed
    Score: 0.003
  117. Winkelmayer WC, Chandraker A, Alan Brookhart M, Kramar R, Sunder-Plassmann G. A prospective study of anaemia and long-term outcomes in kidney transplant recipients. Nephrol Dial Transplant. 2006 Dec; 21(12):3559-66.
    View in: PubMed
    Score: 0.003
  118. Josephson MA, Williams JW, Chandraker A, Randhawa PS. Polyomavirus-associated nephropathy: update on antiviral strategies. Transpl Infect Dis. 2006 Jun; 8(2):95-101.
    View in: PubMed
    Score: 0.003
  119. Martins PN, Chandraker A, Tullius SG. Modifying graft immunogenicity and immune response prior to transplantation: potential clinical applications of donor and graft treatment. Transpl Int. 2006 May; 19(5):351-9.
    View in: PubMed
    Score: 0.003
  120. Winkelmayer WC, Kramar R, Curhan GC, Chandraker A, Endler G, F?dinger M, H?rl WH, Sunder-Plassmann G. Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study. J Am Soc Nephrol. 2005 Jan; 16(1):255-60.
    View in: PubMed
    Score: 0.002
  121. Goggins WC, Pascual MA, Powelson JA, Magee C, Tolkoff-Rubin N, Farrell ML, Ko DS, Williams WW, Chandraker A, Delmonico FL, Auchincloss H, Cosimi AB. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation. 2003 Sep 15; 76(5):798-802.
    View in: PubMed
    Score: 0.002
  122. Kist-van Holthe JE, Gasser M, Womer K, Najafian N, Dong V, Samsonov DV, Geehan CS, Chandraker A, Sayegh MH, Waaga AM. Regulatory functions of alloreactive Th2 clones in human renal transplant recipients. Kidney Int. 2002 Aug; 62(2):627-31.
    View in: PubMed
    Score: 0.002
  123. Waaga AM, Gasser M, Kist-van Holthe JE, Najafian N, M?ller A, Vella JP, Womer KL, Chandraker A, Khoury SJ, Sayegh MH. Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo. J Clin Invest. 2001 Apr; 107(7):909-16.
    View in: PubMed
    Score: 0.002
  124. Tzianabos AO, Chandraker A, Kalka-Moll W, Stingele F, Dong VM, Finberg RW, Peach R, Sayegh MH. Bacterial pathogens induce abscess formation by CD4(+) T-cell activation via the CD28-B7-2 costimulatory pathway. Infect Immun. 2000 Dec; 68(12):6650-5.
    View in: PubMed
    Score: 0.002
  125. Magee CC, Azuma H, Knoflach A, Denton MD, Chandraker A, Iyer S, Buelow R, Sayegh M. In vitro and in vivo immunomodulatory effects of RDP1258, a novel synthetic peptide. J Am Soc Nephrol. 1999 Sep; 10(9):1997-2005.
    View in: PubMed
    Score: 0.002
  126. Onodera K, Chandraker A, Schaub M, Stadlbauer TH, Korom S, Peach R, Linsley PS, Sayegh MH, Kupiec-Weglinski JW. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses. J Immunol. 1997 Aug 15; 159(4):1711-7.
    View in: PubMed
    Score: 0.001
  127. Akalin E, Chandraker A, Sayegh M, Turka LA. Role of the CD28:B7 costimulatory interaction in alloimmune responses. Kidney Int Suppl. 1997 Mar; 58:S8-10.
    View in: PubMed
    Score: 0.001
  128. Knoflach A, Chandraker A, Sayegh MH. Chronic rejection from bedside to bench: role of T cells. Ann Transplant. 1997; 2(2):53-60.
    View in: PubMed
    Score: 0.001
  129. Renwick DS, Chandraker A, Bannister P. Missed neuroleptic malignant syndrome. BMJ. 1992 Mar 28; 304(6830):831-2.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.